The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[((3S,1'R)-3-Amino-3-carboxy)propyl][(4-hydroxy-5-methoxy-3-nitrophenyl)hydroxymethyl]phosphinic Acid ID: ALA4085558
PubChem CID: 124425164
Max Phase: Preclinical
Molecular Formula: C12H17N2O9P
Molecular Weight: 364.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc([C@H](O)P(=O)(O)CC[C@H](N)C(=O)O)cc([N+](=O)[O-])c1O
Standard InChI: InChI=1S/C12H17N2O9P/c1-23-9-5-6(4-8(10(9)15)14(19)20)12(18)24(21,22)3-2-7(13)11(16)17/h4-5,7,12,15,18H,2-3,13H2,1H3,(H,16,17)(H,21,22)/t7-,12+/m0/s1
Standard InChI Key: PEXVMHLARUAHNC-JVXZTZIISA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
6.9901 -7.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9890 -8.1288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6970 -8.5378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4067 -8.1283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4038 -7.3057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6952 -6.9004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2823 -6.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5747 -7.3096 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.8669 -6.9012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1593 -7.3100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4515 -6.9015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7439 -7.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4513 -6.0843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0361 -6.9019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7441 -8.1275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5676 -6.4921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5676 -8.1265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1100 -6.8944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8192 -7.3004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1069 -6.0772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2821 -6.0837 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1150 -8.5358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6968 -9.3550 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9890 -9.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 1 1
12 14 1 0
12 15 2 0
8 16 2 0
8 17 1 0
5 18 1 0
18 19 1 0
18 20 2 0
7 21 1 1
4 22 1 0
3 23 1 0
23 24 1 0
M CHG 2 18 1 19 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.25Molecular Weight (Monoisotopic): 364.0672AlogP: 0.37#Rotatable Bonds: 8Polar Surface Area: 193.45Molecular Species: ZWITTERIONHBA: 8HBD: 5#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 0.86CX Basic pKa: 9.53CX LogP: -2.64CX LogD: -5.97Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.24Np Likeness Score: 0.34
References 1. Selvam C, Lemasson IA, Brabet I, Oueslati N, Karaman B, Cabaye A, Tora AS, Commare B, Courtiol T, Cesarini S, McCort-Tranchepain I, Rigault D, Mony L, Bessiron T, McLean H, Leroux FR, Colobert F, Daniel H, Goupil-Lamy A, Bertrand HO, Goudet C, Pin JP, Acher FC.. (2018) Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites., 61 (5): [PMID:29397723 ] [10.1021/acs.jmedchem.7b01438 ]